<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4546</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">https://doi.org/10.31782/IJCRR.2022.141310</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>&#13;
	In-Vitro Antioxidant Activites of Novel Synthesized Copper (II) Complexes&#13;
&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tahir</surname><given-names>Muhammad</given-names></name></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Muhammad Shahab</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bilal</surname><given-names>Muhammad</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ahmad</surname><given-names>Ashfaq</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ahmad</surname><given-names>Mukhtar</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>5</day><month>07</month><year>2022</year></pub-date><volume>3)</volume><issue/><fpage>60</fpage><lpage>64</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>&#13;
	Introduction: The term radical is originally implied, to a portion of a molecule that cannot exist independently in nature. The Development of these radicals is driven by thermal hemolysis, high-energy radiation and photolysis. Free radical attacks cause cell damage and homeostatic disruption. Targets of free radicals are all kinds of molecules in the body, such as lipids, nucleic acids and proteins are the major targets. Antioxidants are substances capable of slowing or stopping oxidation pathways that occur under the effect of reactive oxygen moieties or free atmospheric oxygen. Objectives: The main objective of the present study was to judge the advantages of the newly synthesized Copper (II) complexes in contrast to oxidative stress caused by free radicals utilizing different assays. Methods: The antioxidant ability of Cu (II) complexes were measured employing different assays including, DPPH free radical scavenging ability, ferric reducing antioxidant potential (FRAF) and total antioxidant ability assay. Results: In the DPPH scavenging potential assay, ferric reducing antioxidant potential and total antioxidant ability assay, RI-1 complex was studied to be more spectacular among the copper(II) complexes. Inhibiting ability of the complexes was RI-1 __ampersandsigngt; NM-3 __ampersandsigngt; AM-2 __ampersandsigngt; SR-3. The Antioxidant scavenging potential was conformed as dose-dependent which increases with the increase of complex concentration. Conclusion: The Copper (II) complexes were found to have high antioxidant abilities.&#13;
&#13;
</p></abstract><kwd-group><kwd>Antioxidants</kwd><kwd> Cu (II) complexes</kwd><kwd> DPPH</kwd><kwd> Free radicals</kwd><kwd> FRAF</kwd><kwd> Total antioxidant ability assay</kwd></kwd-group></article-meta></front></article>
